Description
Overview
Harvard Pulmonary and Critical Care Medicine 2025 is a comprehensive on-demand education program designed to provide the latest updates in evaluation, diagnosis, treatment, procedures, and management of challenging cases in pulmonary and critical care medicine. This course addresses a broad range of pulmonary conditions and critical care issues, supporting clinicians in enhancing patient care through current evidence-based practices.
On-demand pulmonology education — accessible anytime, anywhere.
Agenda
This course includes a detailed syllabus and interactive sessions focusing on the practical management of pulmonary and critical care conditions. The content facilitates clinical expertise development through case discussions and evidence-based guidelines.
- Idiopathic Pulmonary Fibrosis (IPF)
- Acute Respiratory Distress Syndrome (ARDS)
- Sarcoidosis
- Lung Transplantation
- Bronchiectasis
- Cystic Fibrosis
- Lung Nodules
- Lung Cancer
- Sepsis
- Pleural Disease
- Pneumonia
- Tuberculosis
- Thromboembolism
- Chronic Cough
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Occupational and Environmental Lung Disease
- Interstitial Lung Disease
- Gastroesophageal Reflux Disease (GERD)
- Neurologic Issues in the ICU
- Sleep-Disordered Breathing
- Post-Acute Sequelae of COVID-19
- Surgical Emergencies
- Atypical Mycobacterial Disease
- Pulmonary Hypertension
- Cardiopulmonary Disorders
- Complications from Cardiac Arrest
- Hypersensitivity Pneumonitis
- Acute Respiratory Failure
The program also covers crucial clinical updates, including:
- The most current guidelines for treating sepsis
- Evidence-based treatment of ARDS
- State of the art in interventional pulmonology
- High-flow oxygen therapy for respiratory failure
- Updates on biologics in asthma and other lung diseases
- New concepts in the use of vasopressors in septic shock
- New drugs and combinations in pulmonary hypertension
- New evidence on sedation, analgesia, and early mobility in the ICU
- Point-of-care pulmonary ultrasound in the intensive care unit
- Lung microbiome: emerging implications for lung health
- Emerging evidence for targeted temperature management
- Evaluating occupational and environmental lung disease
- Steroid-sparing agents for interstitial lung disease
- Pulmonary embolus: the latest treatment strategies
- State-of-the-art management of the critically ill patient
- Guidance to conduct end-of-life discussions
- Updates in pulmonary pathology
- New treatment options in cystic fibrosis
- Handling neurologic and surgical emergencies in the medical ICU
- New approaches that improve outcomes for patients with unexplained chronic cough
Interactive elements include live streaming, electronic Q&A sessions, and opportunities to engage with nationally and internationally recognized leaders in pulmonary and critical care medicine.
Format: Online streaming with live and recorded sessions, electronic Q&A
Syllabus available as PDF.
Speakers
This course features nationally and internationally recognized leaders in pulmonary and critical care medicine, delivering masterful presentations and practical recommendations. Interactive sessions support real-world clinical discussion and knowledge reinforcement.
Target Audience
This course is intended for pulmonologists, critical care physicians, internists, emergency medicine specialists, respiratory therapists, and other healthcare professionals involved in the management of patients with complex pulmonary and critical care conditions.
Why This Topic Matters
Harvard Pulmonary and Critical Care Medicine 2025 addresses current challenges in pulmonology and critical care, offering comprehensive updates aligned with recent advances and guidelines. As a clinical specialty, pulmonary and critical care medicine requires ongoing education to manage complex respiratory disorders effectively.
MedHub Central provides reliable access to this in-depth learning material, supporting healthcare professionals in maintaining expertise and clinical confidence through a flexible, on-demand format.
